These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 2041411)

  • 21. Potential interactions between cholesterol lowering drugs and protease inhibitors.
    Notes Undergr; 1998; (No 37):8. PubMed ID: 11365822
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Perspectives in cholesterol-lowering therapy: the role of ezetimibe, a new selective inhibitor of intestinal cholesterol absorption.
    Bruckert E; Giral P; Tellier P
    Circulation; 2003 Jul; 107(25):3124-8. PubMed ID: 12835406
    [No Abstract]   [Full Text] [Related]  

  • 23. [Stanols--a new perspective in treatment of hypercholesterolemia?].
    Jankowski P; Bilo G; Bryniarski L; Bryniarska-Mirek E; Pajak A
    Przegl Lek; 2000; 57(11):655-8. PubMed ID: 11293214
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Cholesterol synthesis inhibitors: lowering of cholesterol for everybody?].
    Westendorp RG; Smelt AH
    Ned Tijdschr Geneeskd; 1996 Feb; 140(8):411-4. PubMed ID: 8720812
    [No Abstract]   [Full Text] [Related]  

  • 25. Should cholesterol-lowering drugs be used routinely to treat moderate hypercholesterolemia in patients with serum cholesterol levels of 6.20 to 6.85 mmol/L (240 to 265 mg/dL). An opposing view.
    Zweig S
    J Fam Pract; 1988 Jun; 26(6):670-5. PubMed ID: 3132527
    [No Abstract]   [Full Text] [Related]  

  • 26. [Effectiveness and tolerability of simvastatin in patients with moderate-to-severe hypercholesterolemia. Results of a 12-month study].
    Ghizzoni G; Rusconi C; Faggiano P; Sabatini T; Oneglia C; Gardini A
    Minerva Cardioangiol; 1993 Mar; 41(3):105-9. PubMed ID: 8510811
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of ezetimibe/simvastatin on lipoprotein subfractions in patients with primary hypercholesterolemia: an exploratory analysis of archived samples using two commercially available techniques.
    Ose L; Reyes R; Johnson-Levonas AO; Sapre A; Tribble DL; Musliner T
    Clin Ther; 2007 Nov; 29(11):2419-32. PubMed ID: 18158082
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Disorders of lipid metabolism--diagnosis and therapy in general practice. 4: Therapy of hypercholesterolemia--drug treatment].
    Richter WO
    Fortschr Med; 1996 May; 114(14):177-8. PubMed ID: 8707237
    [No Abstract]   [Full Text] [Related]  

  • 29. Effect of a chronic therapy with the pineal hormone melatonin on cholesterol levels in idiopathic hypercholesterolemic patients.
    Pittalis S; Lissoni P; Giani L; Casati M; Kropacek N; Orfanò S; Giavolucci F; Merlini D
    Recenti Prog Med; 1997 Sep; 88(9):401-2. PubMed ID: 9323901
    [No Abstract]   [Full Text] [Related]  

  • 30. Management of high blood cholesterol.
    Smith MD; McGhan WF
    Bus Health; 1996 Apr; 14(4):67-8, 70, 72-4. PubMed ID: 10157682
    [No Abstract]   [Full Text] [Related]  

  • 31. Efficacy of low-dose cholesterol-lowering drug therapy in men with moderate hypercholesterolemia.
    Denke MA; Grundy SM
    Arch Intern Med; 1995 Feb; 155(4):393-9. PubMed ID: 7848022
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Lowering cholesterol: how low is low enough?].
    Czuriga I; Edes I
    Orv Hetil; 2006 Jul; 147(29):1349-56. PubMed ID: 16941825
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term effect of magnesium pyridoxal 5-phosphate glutamate in rabbits developing hypercholesterolemia.
    Panagiotopoulos T; Ketelsen UP; Schmidt A; Heuck CC
    Arzneimittelforschung; 1986 Aug; 36(8):1210-5. PubMed ID: 3778558
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Statins. Cholesterol-lowering and more in a pill.
    Mayo Clin Health Lett; 2001 Dec; 19(12):4-5. PubMed ID: 11766516
    [No Abstract]   [Full Text] [Related]  

  • 35. Medicines for lowering cholesterol.
    Am Fam Physician; 2011 Sep; 84(5):561-2. PubMed ID: 21888307
    [No Abstract]   [Full Text] [Related]  

  • 36. Hormone replacement and simvastatin in the therapy of hypercholesterolemic postmenopausal women.
    Averbuch M; Ayalon D; Eckstein N; Dotan I; Shapira I; Levo Y; Pines A
    J Med; 1998; 29(5-6):343-50. PubMed ID: 10503169
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [HMG-CoA-reductase inhibitors: a new principle in the treatment of hypercholesterolemia].
    Saxenhofer H; Weidmann P
    Ther Umsch; 1990 Jun; 47(6):509-13. PubMed ID: 2375007
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Hyperlipidemia: decreasing lipid values and effects of statins].
    Mathes P
    Z Kardiol; 2002; 91 Suppl 2():25-9. PubMed ID: 12436762
    [No Abstract]   [Full Text] [Related]  

  • 39. [Consensus agreement on controlling blood cholesterol in Spain].
    Med Clin (Barc); 1990 Apr; 94(13):505-9. PubMed ID: 2192200
    [No Abstract]   [Full Text] [Related]  

  • 40. The efficacy and safety of fluvastatin in hypercholesterolemia in renal transplant recipients.
    Ghods AJ; Milanian I; Arghani H; Ghadiri G
    Transplant Proc; 1995 Oct; 27(5):2579-80. PubMed ID: 7482835
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.